SequelSEC

Kaya Holdings, Inc. KAYS

Pharmaceutical Preparations · CIK 0001530746 · Fiscal year ends 1231

Revenue
$7.13K
Fiscal year ended 2024-12-31
Operating income
-$2.02M
Fiscal year ended 2024-12-31
Free cash flow
-$857.96K
Fiscal year ended 2024-12-31

Kaya Holdings, Inc. (KAYS) reported revenue of $7.13K and net income of -$2.08M for the fiscal year ended 2024-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Kaya Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Kaya Holdings, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$7.13K$196.29K$685.38K$889.90K$1.03M$1.01M
Cost of revenue$7.50K$81.34K$225.11K$279.33K$310.68K$410.25K
Gross profit-$366$114.95K$460.27K$610.57K$718.86K$604.02K
Operating income-$2.02M-$1.02M-$1.71M-$1.43M-$1.84M-$2.26M
Net income-$2.08M$1.61M-$3.58M$9.72M-$12.30M$7.52M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 257.72Mshares 203.74MUnavailableUnavailableUnavailableUnavailable
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailable$23.33K$23.33K$93.91K$0Unavailable
Diluted EPS$-0.07$0.01UnavailableUnavailable$-0.92$0.02
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$605.39K$269.77K$525.86K$780.46K$720.52K$932.55K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Kaya Holdings, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Cash & equivalentsUnavailable$29.11K$18.33K$565.98K$43.16K$86.97K
Total assets$216.37K$215.86K$843.24K$1.57M$2.30M$2.65M
Current assets$67.94K$96.96K$58.48K$631.43K$102.92K$202.75K
Total liabilities$17.34M$15.97M$18.45M$15.98M$27.22M$16.15M
Current liabilities$8.10M$7.40M$10.42M$8.09M$20.30M$10.05M
Total equity incl. NCI-$17.13M-$15.75M-$17.60M-$14.41M-$24.93M-$13.49M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$90$9.26K$11.99K$51.48K$47.62K$108.01K
Accounts receivable$10.36K$11.05K$10.67KUnavailableUnavailableUnavailable
Goodwill$20.96K$23.68K$22.19KUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$586.82KUnavailableUnavailable$1.99KUnavailableUnavailable

Cash flow

Kaya Holdings, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Operating cash flow-$830.82K-$1.18M-$918.80K-$1.04M-$289.62K-$774.88K
Capital expenditures$27.14KUnavailableUnavailable$11.72KUnavailableUnavailable
Investing cash flow$4.01K$812.86K$17.18K$1.27M-$31.69K-$19.67K
Financing cash flow$1.00M$245.00K$370.00K$296.00K$277.50K$770.00K
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensationUnavailableUnavailableUnavailableUnavailable$263.99K$280.30K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$5.88K$11.84K$21.94K$119.04K$141.73KUnavailable

Derived

Kaya Holdings, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Free cash flow-$857.96KUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin-5.1%58.6%67.2%68.6%69.8%59.6%
Operating margin-28343.5%Unavailable-249.7%-160.7%-178.2%-223.3%
FCF margin-12026.3%UnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailable27.6%
Current ratio0.01x0.01x0.01x0.08x0.01x0.02x
Revenue YoY growth-96.4%-71.4%-23.0%-13.6%1.5%Unavailable
Net margin-29168.2%Unavailable-521.8%1092.7%-1194.4%741.6%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue380.4%UnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open KAYS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2025-11-20View SEC filing
10-Q · Filed 2025-08-27View SEC filing
10-Q · Filed 2025-05-21View SEC filing
10-K/A · Filed 2025-05-19View SEC filing
10-K · Filed 2025-04-29View SEC filing
10-Q · Filed 2024-11-22View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.